Cardiovascular Revascularization Medicine
Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial
Randomized trial in 260 peopleTirzepatide
Papers on major adverse valve events
1 paper